FREE DELIVERY ON ALL US ORDERS OVER $50 →
WHYZ Learn
← Back to Ashwagandha

Ashwagandha Dosage: How Much, When, and Which Extract

Updated April 11, 2026 by WHYZ Editorial Team

Quick Answer

The clinically studied dose is 300-600 mg/day of standardized root extract (KSM-66 or equivalent at 5% withanolides). The landmark stress RCT used 300 mg twice daily for 60 days. For Sensoril, 125-250 mg/day is typical due to higher withanolide concentration. Start at 300 mg/day for 1-2 weeks before increasing.

What Is the Correct Ashwagandha Dosage?

Getting the dose right with ashwagandha requires understanding one variable that most guides understate: extract type. First, total withanolide content varies 5-7x between products, from under 1.5% in raw root powder to 8-10% in Sensoril. Second, the two most-studied branded extracts (KSM-66 and Sensoril) use different dosing ranges because of different potency per milligram. Third, clinical trial results are extract-specific, meaning a dose that worked for KSM-66 in a published RCT may not produce the same result with an unstandardized root powder. The clinical data below provides dosing frameworks for each major extract type.

What Doses Were Used in Clinical Trials?

Chandrasekhar et al. (2012) used 300 mg of full-spectrum ashwagandha root extract twice daily for 60 days in 64 chronically stressed adults, producing significant cortisol reduction and stress score improvement (PMID: 23439798). First, the total daily dose was 600 mg of a root-only extract with high withanolide concentration. Second, the split-dose protocol (morning and evening) is consistent with maintaining more stable blood levels across a 24-hour period. Third, the 60-day duration suggests a minimum of 8 weeks for measurable stress and cortisol outcomes.

Wankhede et al. (2015) used the same 300 mg twice daily protocol (600 mg total) for 8 weeks in 57 resistance-training men, achieving significant testosterone increase and muscle strength gains (PMID: 26609282). Langade et al. (2019) also used 300 mg twice daily for 10 weeks in insomnia patients, with significant sleep quality improvements (PMID: 31728244).

Salve et al. (2019) compared two dose levels head-to-head: 250 mg/day and 600 mg/day against placebo for 8 weeks (PMID: 32021735). Both doses reduced cortisol and improved sleep quality compared to placebo. The 600 mg/day group showed larger reductions, but the 250 mg/day dose was still statistically significant for cortisol reduction. This finding supports 250 mg/day as a reasonable minimum effective dose for stress-related outcomes.

StudyDaily DoseExtract TypeDurationKey Outcome
Chandrasekhar et al. 2012600 mg (300 mg x 2)Full-spectrum root60 daysCortisol reduction, stress scores improved
Wankhede et al. 2015600 mg (300 mg x 2)Root extract8 weeksTestosterone +96.2 ng/dL, strength gains
Langade et al. 2019600 mg (300 mg x 2)Full-spectrum root10 weeksSleep efficiency 75.6% to 83.5%
Salve et al. 2019250 mg or 600 mgRoot extract8 weeksBoth doses reduced cortisol vs placebo
Lopresti et al. 2019240 mg/dayKSM-668 weeksTestosterone, DHEA-S improvements
Pandit et al. 2024300 mg/dayRoot extract8 weeksStress reduction in chronically stressed adults

How Should You Dose Each Extract Type?

What Is the Correct KSM-66 Dose?

KSM-66 is a full-spectrum root-only extract standardized to at least 5% withanolides, produced using a milk-based extraction process. First, the standard clinical dose is 300 mg twice daily (600 mg total per day), matching the protocols used in the majority of published RCTs. Second, Lopresti et al. (2019) showed positive hormonal effects at 240 mg/day in a crossover design, suggesting lower doses can still produce measurable outcomes (PMID: 30854916). Third, KSM-66 is the most widely studied branded ashwagandha extract, appearing in over 24 published clinical studies spanning stress, sleep, testosterone, and athletic performance.

For most users targeting stress and cortisol reduction, 300-600 mg/day of KSM-66 covers the evidence-based range. Start at 300 mg/day as a single dose for 1-2 weeks, then increase to 600 mg/day (split morning and evening) if tolerated.

What Is the Correct Sensoril Dose?

Sensoril combines ashwagandha root and leaf material, producing a higher total withanolide concentration (8-10%) compared to root-only extracts. First, the typical clinical dose is 125-250 mg/day, approximately 40-50% of the KSM-66 dose due to higher milligram potency. Second, Sensoril’s withanolide profile differs from KSM-66 because leaf tissue contains higher concentrations of withaferin A, which has more potent bioactivity per milligram. Third, higher withaferin A content is a double-edged consideration: more potent per dose but also carries a narrower safety margin, particularly for sensitive individuals.

For Sensoril users, 125 mg/day is a reasonable starting dose. Increase to 250 mg/day after 1-2 weeks if tolerated. Exceeding 250 mg/day of Sensoril without medical guidance is not recommended due to the higher withanolide concentration.

What About Raw Root Powder?

Raw (unstandardized) ashwagandha root powder contains 1-2% withanolides by weight in most commercial products. First, achieving the withanolide equivalent of 600 mg of KSM-66 (which delivers approximately 30 mg of withanolides) would require 1,500-3,000 mg of raw root powder. Second, withanolide content varies between batches and suppliers without standardization testing. Third, several Ayurvedic traditions recommend 3,000-6,000 mg/day of raw root powder, which falls within the range needed to match standardized extract potency. Raw root powder is less predictable than standardized extracts but remains a valid format if users accept the variability.

What Is the Starting Dose Versus Maintenance Dose?

New users should begin conservatively and increase based on tolerance. First, start with 300 mg/day of KSM-66 (or 125 mg/day of Sensoril) as a single morning dose for the first 1-2 weeks to assess gastrointestinal tolerance and rule out drowsiness or headache. Second, increase to 600 mg/day of KSM-66 (split 300 mg morning and 300 mg evening) once tolerance is confirmed. Third, the Akhgarjand et al. (2022) meta-analysis identified 300-600 mg/day as the most effective range for stress outcomes, with dose-response analysis showing diminishing returns above 600 mg/day (PMID: 36017529). Exceeding 600 mg/day of standardized extract without medical supervision is not supported by the current evidence base.

When Is the Best Time to Take Ashwagandha?

Timing depends on the primary goal. First, for stress and cortisol reduction, take the dose in the morning or split morning and evening. The Chandrasekhar et al. (2012) split-dose protocol (morning and evening) produced the most consistent cortisol reduction data. Second, for sleep improvement, take 300-600 mg approximately 30-60 minutes before bed. The Langade et al. (2019) trial administered doses with no specific sleep-related timing instruction but still produced significant sleep improvements, suggesting ashwagandha’s sleep effects are cumulative rather than acutely sedating. Third, for athletic performance and testosterone, take 300 mg in the morning and 300 mg post-workout or evening, matching the Wankhede et al. (2015) twice-daily protocol.

Primary GoalRecommended Timing
Stress and cortisol reduction300 mg morning + 300 mg evening
Sleep improvement300-600 mg 30-60 minutes before bed
Testosterone and athletic performance300 mg morning + 300 mg post-workout or evening
General adaptogenic support300-600 mg morning with food

Taking ashwagandha with food reduces the likelihood of GI discomfort. Some studies administered doses with meals, others without specific food instructions. Absorption differences between fed and fasted states have not been rigorously compared in published trials.

What Should You Look for on an Ashwagandha Label?

Five label elements indicate a trustworthy product. First, a stated withanolide percentage confirms the manufacturer tested and standardized the batch. Look for “5% withanolides” (KSM-66) or “8-10% withanolides” (Sensoril). Second, the specific extract brand name (KSM-66, Sensoril, Witholytin, or equivalent) provides traceability to the clinical literature. Third, “root extract” versus “root and leaf extract” versus “whole plant” describes what part of the plant was used, which affects the withanolide profile. Fourth, a Certificate of Analysis from a third-party lab confirms potency and contaminant testing. Fifth, the total ashwagandha milligrams per capsule or serving, not per “proprietary blend,” allows accurate dosing comparisons.

Should You Cycle Ashwagandha?

Cycling ashwagandha is a common recommendation with limited clinical basis. First, most published RCTs ran 8-12 weeks of continuous use without reported tolerance development. Second, Raut et al. (2012) published an exploratory tolerability study showing good safety over extended dosing periods (PMID: 23125505). Third, the rare hepatotoxicity cases reported in post-market surveillance are a reasonable argument for periodic breaks, since long-term safety data beyond 12 weeks is limited. A practical approach is 8-12 weeks on followed by 2-4 weeks off, which aligns with clinical trial durations and limits cumulative exposure. Continuous long-term use is not contraindicated by published data but has less safety coverage than cycled protocols.

What Conditions Require Dose Modification?

Several conditions warrant reduced dosing or avoidance. First, thyroid disorders: Sharma et al. (2018) showed ashwagandha increased thyroid hormone levels (T3, T4) and decreased TSH in subclinical hypothyroid patients (PMID: 28829155). Hyperthyroid individuals or those on thyroid medication should avoid ashwagandha or use it only under medical supervision. Second, autoimmune conditions: ashwagandha may stimulate immune activity, which could worsen autoimmune diseases like lupus, rheumatoid arthritis, or Hashimoto’s thyroiditis. Third, pregnancy and breastfeeding: insufficient safety data exists. Fourth, sedative medications: ashwagandha may have additive sedating effects. Fifth, diabetes medications: potential additive blood sugar-lowering effect requires monitoring.

See the full Ashwagandha Side Effects Guide for the complete contraindication list.

References

  1. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012, 34(3):255-262. PMID: 23439798.
  2. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015, 12:43. PMID: 26609282.
  3. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and Safety of Ashwagandha Root Extract in Insomnia and Anxiety. Cureus. 2019, 11(9):e5797. PMID: 31728244.
  4. Salve J, et al. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults. Cureus. 2019, 11(12):e6466. PMID: 32021735.
  5. Lopresti AL, Drummond PD, Smith SJ. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha in Aging, Overweight Males. Am J Mens Health. 2019, 13(2). PMID: 30854916.
  6. Akhgarjand C, et al. Does Ashwagandha supplementation have a beneficial effect on anxiety and stress? Phytother Res. 2022, 36(11):4115-4124. PMID: 36017529.
  7. Raut AA, et al. Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha in healthy volunteers. J Ayurveda Integr Med. 2012, 3(3):111-114. PMID: 23125505.
  8. Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients. J Altern Complement Med. 2018, 24(3):243-248. PMID: 28829155.
  9. Pandit S, et al. Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial. Nutrients. 2024, 16(9):1365. PMID: 38732539.

Written by WHYZ Editorial Team · Last updated April 2026

Not medical advice. Editorial policy →